58468-5030-1 : NDC 2026 Code

58468-5030-1 : Agalsidase Beta ( )

Additionally :

You can get information about “58468-5030-1” NDC code in 58468-5030-1 in HTML format

HTML | 58468-5030-1 in TXT (Plain Text) format

TXT | 58468-5030-1 in PDF (Portable Document Format)

PDF | 58468-5030-1 in XML format

XML formats.

NDC Code : 58468-5030-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "58468-5030-1",
    "PackageDescription": "1 mL in 1 VIAL (58468-5030-1) ",
    "NDC11Code": "58468-5030-01",
    "ProductNDC": "58468-5030",
    "ProductTypeName": "DRUG FOR FURTHER PROCESSING",
    "ProprietaryName": null,
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Agalsidase Beta",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": null,
    "StartMarketingDate": "20031010",
    "EndMarketingDate": null,
    "MarketingCategoryName": "DRUG FOR FURTHER PROCESSING",
    "ApplicationNumber": null,
    "LabelerName": "Genzyme Corporation",
    "SubstanceName": "AGALSIDASE BETA",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Unfinished",
    "LastUpdate": "2026-01-01",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": null,
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "10-OCT-03",
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}